SEC Form D filing

Biolexis Therapeutics Inc.

Biotech · Series A · Regulation D 506(b) · UT · Filed June 3, 2026

Offering amount

$12.0M

Exemption

Reg D 506(b)

Issuer state

Filing date

June 3, 2026

Signature date

June 3, 2026

CIK

0001914060

Summary

Auto-generated

Biotech therapeutics company, $12M series-a, UT-based.

Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Source

View on SEC EDGAR →Get alerts for filings like this →

FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.